
Mankind Pharma Ltd. (MANKIND): Mankind Pharma Share Price Rises 2.19% Today to Rs 2,483
Updated: 22 Sept 2026 • 2:21 pm
Posted by:

Mankind Pharma Share Price rose today to Rs 2,483, up 2.19% from the previous close of Rs 2,429.85, with the company’s market capitalisation at Rs 95,743.85 crore. The day’s move placed Mankind Pharma Ltd. among the Stocks in News in the Indian Stock Market, even though the supplied data does not establish a company-specific catalyst. The stock opened at Rs 2,445.60, touched a day high of Rs 2,486.70 and a day low of Rs 2,438, while turnover stood at Rs 23.14 crore. This Mankind Pharma Share Price update matters because it combines a clear same-day price rise with a sizeable listed-company footprint and a valuation profile that can be read against healthcare peers. For readers tracking Mankind Pharma Share Price Today, the next focus is on whether the move is sustained through subsequent sessions and how the market continues to assess the stock’s fundamentals, sector context and peer comparison in Univest stock coverage.
Mankind Pharma Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,483 |
| Previous Close | Rs 2,429.85 |
| Today's Move | Rs 53.15 (+2.19%) |
| Open | Rs 2,445.6 |
| High | Rs 2,486.7 |
| Low | Rs 2,438 |
| Turnover | Rs 23.14 crore |
| Market Capitalisation | Rs 95,743.85 crore |
| Market Cap Category | Large Cap |
Mankind Pharma Ltd. (MANKIND) rose to Rs 2,483 from the previous close of Rs 2,429.85, a move of Rs 53.15 or 2.19%. The stock opened at Rs 2,445.6, reached a high of Rs 2,486.7, recorded a low of Rs 2,438.
Mankind Pharma Share Price Today showed a clean upward move, with the stock closing at Rs 2,483 after adding Rs 53.15, or 2.19%, over the previous close. The session range stretched from Rs 2,438 to Rs 2,486.70, which kept the stock close to its intraday peak. The opening price of Rs 2,445.60 also stayed above the previous close, showing that the session started with a firm gap-up versus the last close and then held most of the day’s gains. Turnover of Rs 23.14 crore provides a factual snapshot of traded value for the day. In Mankind Pharma Stock News terms, today’s move is best described as a share price gain supported by a high-of-day finish rather than by any verified company event in the supplied data.
Mankind Pharma Ltd. (MANKIND) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 95,743.85 crore |
| P/E Ratio | 49.13x |
| P/B Ratio | 5.96x |
| ROE | 12.69% |
| ROCE | 13.24% |
| EPS | Rs 49.45 |
| Book Value Per Share | Rs 407.39 |
| Dividend Yield | 0.04% |
Mankind Pharma Ltd. (MANKIND) fundamental metrics show P/E 49.13x, P/B 5.96x, ROE 12.69%, ROCE 13.24%. These figures provide context only and are not a buy or sell signal.
Mankind Pharma Ltd. has a market capitalisation of Rs 95743.85 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 49.13x, P/B at 5.96x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.69% and ROCE of 13.24%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 49.45, book value per share of Rs 407.39, dividend yield of 0.04%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.62x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 49.13x |
| Benchmark Median P/E | 32.62x |
| Benchmark Average P/E | 49.51x |
| Benchmark P/E Range | 3.37x to 747.32x |
| Company P/B Ratio | 5.96x |
| Benchmark Median P/B | 3x |
| Company ROE | 12.69% |
| Benchmark Median ROE | 11.74% |
| Company ROCE | 13.24% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 95,743.85 crore |
| Benchmark Median Market Cap | Rs 746.45 crore |
Mankind Pharma Ltd. (MANKIND) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Mankind Pharma Ltd. (MANKIND) has a P/E ratio of 49.13x, which is above the benchmark median of 32.62x, a difference of +50.61%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Mankind Pharma Ltd. (MANKIND) has a ROE of 12.69%, which is above the benchmark median of 11.74%, a difference of +8.09%. Mankind Pharma Ltd. (MANKIND) has a ROCE of 13.24%, which is below the benchmark median of 13.63%, a difference of -2.86%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,397.93 | 37.05 | 5.18 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,48,664.42 | 85.6 | 14.18 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,82,738.23 | 86.64 | 21.05 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,15,012.19 | 25.67 | 4.3 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,10,793.75 | 33.19 | 3.18 | 11.83 | 16 |
Mankind Pharma Ltd. (MANKIND) has a P/E ratio of 49.13x compared with the displayed peer median of 37.05x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 13.24% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Mankind Pharma Ltd. (MANKIND) has a market capitalisation of Rs 95,743.85 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Mankind Pharma
- Mankind Pharma Share Price rose 2.19% today to Rs 2,483, after closing above the previous close of Rs 2,429.85.
- The day’s high was Rs 2,486.70, which kept Mankind Pharma Share Price close to the session peak.
- Market capitalisation stood at Rs 95,743.85 crore, giving Mankind Pharma Stock News a large listed-company context.
- P/E was 49.13, P/B was 5.96, ROE was 12.69 and ROCE was 13.24 in the latest supplied data.
- In the same-industry benchmark, Mankind Pharma Share Price sits above the median on ROE and above the median on P/B.
About Mankind Pharma
Mankind Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The business context supplied for Mankind Pharma Share Price is that of a large listed pharmaceutical company whose valuation and earnings profile can be compared with other Indian drug makers. Its market capitalisation of Rs 95,743.85 crore places it among the more valuable names in the industry benchmark supplied here. The available data highlights a revenue-generating listed company with EPS of Rs 49.45, book value of Rs 407.39 and dividend yield of 0.04, all of which help explain how the market is framing the stock. For readers tracking Mankind Pharma Company News, the key point is that the company should be assessed through its operating profile, valuation multiples and position in the pharmaceutical peer set. Univest presents this Mankind Pharma Stock News page as a factual market update for investors following the stock’s daily movement.
Track Mankind Pharma Share Price on Univest
Use Mankind Pharma Ltd. (MANKIND) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Mankind Pharma Share Price on Univest for live share price updates, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers monitor Mankind Pharma Share Price Today alongside sector context, peer comparison and company-level financial data in one place. For users following Mankind Pharma Stock News, this makes it easier to review price movement, valuation and company background together.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Mankind Pharma Share Price rising today?
Ans. Mankind Pharma Share Price rose 2.19% to Rs 2,483 today, but the supplied data does not establish a company-specific catalyst. The move is confirmed by the day’s open, high, low and previous close.
What is Mankind Pharma Share Price Today?
Ans. Mankind Pharma Share Price Today is Rs 2,483. The stock gained Rs 53.15 from the previous close of Rs 2,429.85, and the session high reached Rs 2,486.70. The previous close was Rs 2,429.85.
What is Mankind Pharma market capitalisation?
Ans. Mankind Pharma’s market capitalisation is Rs 95,743.85 crore. That places the company far above the same-industry benchmark median of Rs 746.45 crore and above the benchmark average of Rs 14,202.67 crore.
What does Mankind Pharma Share Price indicate on valuation?
Ans. Mankind Pharma Share Price reflects a P/E of 49.13 and a P/B of 5.96. EPS is Rs 49.45 and book value is Rs 407.39, which helps frame the valuation context.
How does Mankind Pharma compare with healthcare peers?
Ans. In the supplied peer set, Mankind Pharma sits above Zydus Lifesciences and Cipla on P/E, but below Divi’s Laboratories and Torrent Pharmaceuticals. Its market cap is also below Sun Pharmaceutical Industries Ltd.
What is Mankind Pharma Share Price fundamental analysis telling investors?
Ans. Mankind Pharma Fundamental Analysis shows ROE of 12.69, ROCE of 13.24 and dividend yield of 0.04. The figures provide profitability and valuation context, but they do not by themselves explain today’s move.
Is Mankind Pharma part of the Healthcare sector?
Ans. Yes, Mankind Pharma belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That sector setting matters because its valuation and return metrics are best read against same-industry peers.
Where can I track Mankind Pharma Share Price on Univest?
Ans. Readers can track Mankind Pharma Share Price on Univest for live updates, company ratios, shareholding pattern, 52-week levels and market insights. The platform also helps compare the stock with listed healthcare peers.
Recent Articles

Interglobe Aviation Ltd. (INDIGO): Interglobe Aviation Share Price Rises 2.13% Today
22 September 2026

Aequs Ltd. (AEQUS) Share Price Rises 5.03% Today; Market Cap at Rs 15,552.74 Cr
22 September 2026

VISHAL MEGA MART LIMITED (VMM): VISHAL MEGA MART Share Price Rises 2.22% Today to Rs 103.75
22 September 2026

Hatsun Agro Product Ltd. (HATSUN): Hatsun Agro Product Share Price Rises 2.95% to Rs 1,165
22 September 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Interglobe Aviation Ltd. (INDIGO): Interglobe Aviation Share Price Rises 2.13% Today
Aequs Ltd. (AEQUS) Share Price Rises 5.03% Today; Market Cap at Rs 15,552.74 Cr
VISHAL MEGA MART LIMITED (VMM): VISHAL MEGA MART Share Price Rises 2.22% Today to Rs 103.75
Hatsun Agro Product Ltd. (HATSUN): Hatsun Agro Product Share Price Rises 2.95% to Rs 1,165
Sintercom India Ltd. (SINTERCOM): Sintercom India Share Price rises 8.38%: Sintercom India Share Price Today
Popular this week
Supra Pacific Financial Services Ltd. (SUPRAPFSL): Supra Pacific Financial Services Share Price rises 8.42% today to Rs 31.95

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





